ConductScience.org, home

Paper41375813

When Blood Disorders Meet Cancer: Uncovering the Oncogenic Landscape of Sickle Cell Disease.

Casadessus E and 5 others. J Clin Med, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. When Blood Disorders Meet Cancer: Uncovering the Oncogenic Landscape of Sickle Cell Disease. Papers, record 41375813. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41375813

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
When Blood Disorders Meet Cancer: Uncovering the Oncogenic Landscape of Sickle Cell Disease.
PubMed
Journal
J Clin Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-12-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Casadessus EElise
2Saby MManonhttps://orcid.org/0000-0003-2110-5576
3Forté SStéphaniehttps://orcid.org/0000-0003-2434-9234
4Pastore YYves
5Lavallée VPVincent-Philippe
6Pincez TThomashttps://orcid.org/0000-0002-9412-333X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References143

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136551957Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review.Biomedicines2022https://conductscience.org/library/papers/36551957PubMed
230218578Effects of hydroxyurea on CNV induction in the mouse germline.Environ Mol Mutagen2018https://conductscience.org/library/papers/30218578PubMed
325203083Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.JAMA2014https://conductscience.org/library/papers/25203083PubMed
429974957Potential involvement of ubiquitin-proteasome system dysfunction associated with oxidative stress in the pathogenesis of sickle cell disease.Br J Haematol2018https://conductscience.org/library/papers/29974957PubMed
532161723Bone Marrow Senescence and the Microenvironment of Hematological Malignancies.Front Oncol2020https://conductscience.org/library/papers/32161723PubMed
628830890Increased risk of leukemia among sickle cell disease patients in California.Blood2017https://conductscience.org/library/papers/28830890PubMed
732437728Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives.Immunol Lett2020https://conductscience.org/library/papers/32437728PubMed
832855279Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease.Haematologica2021https://conductscience.org/library/papers/32855279PubMed
922918118DNA damage in leukocytes of sickle cell anemia patients is associated with hydroxyurea therapy and with HBB*S haplotype.Mutat Res2012https://conductscience.org/library/papers/22918118PubMed
1029542687Sickle cell disease.Nat Rev Dis Primers2018https://conductscience.org/library/papers/29542687PubMed
1125426838Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.N Engl J Med2014https://conductscience.org/library/papers/25426838PubMed
1228587497Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease.Leuk Lymphoma2018https://conductscience.org/library/papers/28587497PubMed
1328577651Telomere length correlates with disease severity and inflammation in sickle cell disease.Rev Bras Hematol Hemoter2017https://conductscience.org/library/papers/28577651PubMed
1431693163Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention.Br J Haematol2020https://conductscience.org/library/papers/31693163PubMed
1528803919Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.Cell Stem Cell2017https://conductscience.org/library/papers/28803919PubMed
1631880407Haploidentical bone marrow transplantation in a patient with sickle cell disease and acute myeloid leukemia.Pediatr Transplant2020https://conductscience.org/library/papers/31880407PubMed
1718485083Delayed adverse vascular events after splenectomy in hereditary spherocytosis.J Thromb Haemost2008https://conductscience.org/library/papers/18485083PubMed
184502362Frequency and prognosis of coexisting sickle cell disease and acute leukemia in children.Clin Pediatr (Phila)1972https://conductscience.org/library/papers/4502362PubMed
1923746838The hallmarks of aging.Cell2013https://conductscience.org/library/papers/23746838PubMed
2017645642Sickle cell disease: role of reactive oxygen and nitrogen metabolites.Clin Exp Pharmacol Physiol2007https://conductscience.org/library/papers/17645642PubMed

See all 143 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42194209Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome?Children (Basel)2026https://conductscience.org/library/papers/42194209

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41375813

GET https://conductscience.org/api/papers/v1/41375813/references?page=2